Sheri serves as the Vice President of Commercial Operations, Analytics and Insights, and New Product Planning at Xeris Pharmaceuticals, Inc., where she plays a pivotal role in shaping the strategic direction of the company’s portfolio, particularly in the specialty pharmaceutical sector focused on rare diseases...
Sheri serves as the Vice President of Commercial Operations, Analytics and Insights, and New Product Planning at Xeris Pharmaceuticals, Inc., where she plays a pivotal role in shaping the strategic direction of the company’s portfolio, particularly in the specialty pharmaceutical sector focused on rare diseases and orphan drugs. With a robust background in biopharmaceuticals and medical devices, Sheri is recognized for her collaborative approach and analytical mindset, which have been instrumental in driving successful product launches and commercial assessments.
In her current role, Sheri has operationalized and resourced three critical functional areas: Commercial Operations, Analytics & Insights, and New Product Planning. Her leadership has been vital in generating comprehensive financial forecasts and demand planning, which are essential for quantifying unmet market needs. By leveraging patient, caregiver, and healthcare professional insights, she has supported Xeris through its IPO and subsequent funding rounds, ensuring that the company remains well-positioned to meet market demands.
Sheri's expertise extends to identifying and integrating advanced CRM tools, such as the Veeva platform, and establishing a robust business intelligence system that enhances decision-making processes. Her skills in pricing optimization, regulatory requirements, and sales force development have not only streamlined operations but also fortified Xeris's competitive edge in a challenging landscape. As a leader, Sheri exemplifies business acumen and strategic foresight, making her an invaluable asset to Xeris Pharmaceuticals and the broader biopharmaceutical community.
